Panel recommends extending time between doses to 8 and 12 weeks to improve efficacy
The Oxford/AstraZeneca vaccine has been recommended by the World Health Organization for use in all adults, despite limited data on the jab’s efficacy for older people, which has caused some countries in Europe to rule out its use in the over-65s.
The WHO’s Strategic Advisory Group of Experts (Sage) said the vaccine should be given in two doses, eight to 12 weeks apart, bolstering the stand the UK government has taken in its mass vaccination programme.
